CH644271A5 - Verfahren zur herstellung von fruehsommer-meningoenzephalitis-virus-vakzinen. - Google Patents

Verfahren zur herstellung von fruehsommer-meningoenzephalitis-virus-vakzinen. Download PDF

Info

Publication number
CH644271A5
CH644271A5 CH1122379A CH1122379A CH644271A5 CH 644271 A5 CH644271 A5 CH 644271A5 CH 1122379 A CH1122379 A CH 1122379A CH 1122379 A CH1122379 A CH 1122379A CH 644271 A5 CH644271 A5 CH 644271A5
Authority
CH
Switzerland
Prior art keywords
virus
density gradient
suspension
subjected
gradient ultracentrifugation
Prior art date
Application number
CH1122379A
Other languages
German (de)
English (en)
Inventor
Franz Dr Heinz
Christian Prof Dr Kunz
Johann Dr Fauma
Otto Dr Schwarz
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of CH644271A5 publication Critical patent/CH644271A5/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B28—WORKING CEMENT, CLAY, OR STONE
    • B28D—WORKING STONE OR STONE-LIKE MATERIALS
    • B28D1/00—Working stone or stone-like materials, e.g. brick, concrete or glass, not provided for elsewhere; Machines, devices, tools therefor
    • B28D1/02—Working stone or stone-like materials, e.g. brick, concrete or glass, not provided for elsewhere; Machines, devices, tools therefor by sawing
    • B28D1/06—Working stone or stone-like materials, e.g. brick, concrete or glass, not provided for elsewhere; Machines, devices, tools therefor by sawing with reciprocating saw-blades
    • B28D1/068—Components, e.g. guiding means, vibrations damping means, frames, driving means, suspension
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Mining & Mineral Resources (AREA)
  • Mechanical Engineering (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CH1122379A 1978-12-22 1979-12-18 Verfahren zur herstellung von fruehsommer-meningoenzephalitis-virus-vakzinen. CH644271A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT922078A AT358167B (de) 1978-12-22 1978-12-22 Verfahren zur herstellung von fruehsommer- -meningoenzephalitis-virus (fsme-virus)- -vakzinen

Publications (1)

Publication Number Publication Date
CH644271A5 true CH644271A5 (de) 1984-07-31

Family

ID=3612255

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1122379A CH644271A5 (de) 1978-12-22 1979-12-18 Verfahren zur herstellung von fruehsommer-meningoenzephalitis-virus-vakzinen.

Country Status (11)

Country Link
AT (1) AT358167B (fr)
BE (1) BE880732A (fr)
CH (1) CH644271A5 (fr)
CS (1) CS223975B2 (fr)
DE (1) DE2950004C2 (fr)
FR (1) FR2444466A1 (fr)
GB (1) GB2038179B (fr)
IT (1) IT1126676B (fr)
SE (1) SE447789B (fr)
SU (2) SU1003738A3 (fr)
YU (1) YU42204B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT384363B (de) * 1982-10-05 1987-11-10 Immuno Ag Verfahren zur verwendung von antigenreaktiven peptiden zur herstellung von gegen fsme-virusinfektionen wirksamen vakzinen
AT385203B (de) * 1985-04-26 1988-03-10 Immuno Ag Verfahren zur herstellung einer fruehsommermeningoenzephalitis-virus (fsme-virus)-vakzine
US5719051A (en) * 1989-12-22 1998-02-17 Immuno Aktiengesellschaft Perfusion system and a method for the large scale production of virus or virus antigen
AT393356B (de) * 1989-12-22 1991-10-10 Immuno Ag Verfahren zur herstellung von fsme-virus-antigen
AT393277B (de) * 1990-01-04 1991-09-25 Immuno Ag Verfahren zur herstellung von fruehsommer- meningoenzephalitis-virus (fsme-virus)-antigen
IT1305405B1 (it) * 1998-02-18 2001-05-04 Augusto Cappelli Telaio di taglio per la segagione di blocchi di pietra, roccia,granito, marmo, o simili.
RU2203089C2 (ru) * 2001-06-28 2003-04-27 Федеральное Государственное унитарное предприятие научно-производственное объединение "Вирион" Способ получения вакцины клещевого энцефалита

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1152626A (en) * 1967-07-07 1969-05-21 Merck & Co Inc Rubella Vaccine
GB1453035A (en) * 1972-12-21 1976-10-20 Secr Defence Virus vaccine production

Also Published As

Publication number Publication date
DE2950004A1 (de) 1980-07-03
IT1126676B (it) 1986-05-21
SU1318149A3 (ru) 1987-06-15
ATA922078A (de) 1980-01-15
IT7928341A0 (it) 1979-12-21
SE447789B (sv) 1986-12-15
GB2038179B (en) 1983-02-16
FR2444466B1 (fr) 1983-07-08
YU42204B (en) 1988-06-30
CS223975B2 (en) 1983-11-25
BE880732A (fr) 1980-04-16
AT358167B (de) 1980-08-25
FR2444466A1 (fr) 1980-07-18
DE2950004C2 (de) 1991-04-18
YU311779A (en) 1983-10-31
SE7910054L (sv) 1980-06-23
SU1003738A3 (ru) 1983-03-07
GB2038179A (en) 1980-07-23

Similar Documents

Publication Publication Date Title
DE69628564T2 (de) Verfahren zur reinigung von viren mit chromatographie
DE2517596C2 (de) (R)-3-(2-Deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo [4,5-d] [1,3]diazepin-8-ol und Verfahren zu dessen Herstellung
DE2516274C2 (de) Verfahren zum Herstellen eines abgeschwächten Zytomegalie-Virus-Impfstoffes
EP0509008B1 (fr) Biomasse pour la production de virus/antigenes viraux
DE2950004C2 (de) Verfahren zur Herstellung von Frühsommer-Meningoenzephalitis-Virus(FSME-Virus)-Vakzinen
DE2555169C2 (fr)
DE3877818T2 (de) Verfahren zur beseitigung von pertussisendotoxin, ein pertussistoxoid und seine herstellung.
DE2355094A1 (de) Tetanus-vaccine und verfahren zu deren herstellung
DE3152621C2 (fr)
DE2828073C2 (de) Verfahren zum Kultivieren von Viren
DE2500785C3 (fr)
DE2449530C2 (de) Virusuntereinheitenimpfstoff
DE2508396A1 (de) Verfahren zur gewinnung von virusproteinen, die dabei erhaltenen proteine und diese proteine als wirkstoffe enthaltende arzneimittel
DE69413952T2 (de) Extraktion von zellgebundenem protein von bordetella
DE2440927A1 (de) Verfahren zur herstellung von aktivierten hb-ag-vaccinen
DE2333884C3 (de) Verfahren zum Herstellen von hochgereinigtem Humanalbumin
DE3045990A1 (de) Verfahren zur reinigung von teilchen biologischen ursprungs
DE2805311A1 (de) Respiratorische synzytial-vakzine
DE69632066T2 (de) Verfahren zur reinigung der urease aus helicobacter pylori
DE2634584C3 (de) Atoxisches, immunogenes Produkt aus Tetanus-Toxin
DE1667929A1 (de) Vakzine
DE1617344B2 (de) Verfahren zur herstellung eines tetanus-impfstoffes
CH660125A5 (de) Gereinigtes, entgiftetes endotoxin enthaltende zusammensetzung.
DE2162013C3 (de) Tollwut-Lebendimpfstoff, Verfahren zu seiner Herstellung nd seine Verwendung bei der Bekämpfung von Tollwut
DE3413960A1 (de) Verfahren zur gewinnung von zellkulturen

Legal Events

Date Code Title Description
PL Patent ceased